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INTRODUCTION
Transgenesis is an indispensable technology in biomedical research, 
as it allows manipulating the genome of an organism at will thus 
providing a platform for determining functions of various genes. 
With the advent of high throughput sequencing technologies, valu-
able information about several genes and their spatio temporal 
pattern of expression have been gathered. The technologies have 
also led to generation of a huge database of information about 
potential coding and noncoding regions of the genome that con-
trol development and maintenance of an organism.1–3 However, 
studies of functional genomics are essential to decipher their roles 
and to understand how their altered expressions are correlated to 
physiology, development, and diseases. Although several methods 
of germ line gene transfer are available to make transgenic animals 
for this purpose, they are tedious, time consuming, and expensive. 
For instance, classical method of gene transfer involves microin-
jection of nucleic acids into fertilized eggs, typically yielding low 
success rate of ~10–20%.4,5 Moreover, this technique is beyond 
reach of common researcher, largely due to technical complexi-
ties in adopting skills for micro manipulation of embryos.4 This has 
caused a remarkable delay in functional interpretation of several 
newly found genes in tissue and age specific manner, limiting the 
pace of biological research. For meaningful interpretation of rapidly 
generating knowledge about genomics, it is imperative to establish 
a faster alternative to DNA microinjection mediated transgenesis 
which is easily adaptable, less invasive, and less time consuming.
Alternative to above strenuous technique we had developed 
a method for generation of transgenic mice by directly injecting 
the desired gene in the testis followed by in vivo electroporation.6 
Since, this technique requires expertise in survival surgeries of 
animals, next we developed a two-step nonsurgical electropora-
tion procedure to generate transgenic mice.7 This technique is less 
complicated for small animal like mice but due to involvement of 
electric shock it may not be feasible for large animal transgenesis. 
Moreover, due to much variation in testis size and scrotal thickness 
the standardization of voltage parameters remains challenging. This 
led us to further develop an innovative and simple method to make 
transgenesis easy.
Treatment with hypotonic Tris-HCl solution result in reduced 
osmolarity and leads to hypotonic-swelling of germ cells which 
eventually kill them with increased hypotonicity8 and this kind of 
hypotonic-swelling in erythrocyte lead to uptake of surrounding 
molecules such as nucleosides inside the cell.9 We sought to exploit 
this property of the germ cell in testis, and hypothesized that a 
hypotonic Tris-HCl solution at certain hypotonic concentration 
might allow the germ cells to internalize the surrounding solutes 
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Our ability to decipher gene sequences has increased enormously with the advent of modern sequencing tools, but the ability to 
divulge functions of new genes have not increased correspondingly. This has caused a remarkable delay in functional interpreta-
tion of several newly found genes in tissue and age specific manner, limiting the pace of biological research. This is mainly due to 
lack of advancements in methodological tools for transgenesis. Predominantly practiced method of transgenesis by pronuclear 
DNA-microinjection is time consuming, tedious, and requires highly skilled persons for embryo-manipulation. Testicular electropor-
ation mediated transgenesis requires use of electric current to testis. To this end, we have now developed an innovative technique 
for making transgenic mice by giving hypotonic shock to male germ cells for the gene delivery. Desired transgene was suspended 
in hypotonic Tris-HCl solution (pH 7.0) and simply injected in testis. This resulted in internalization of the transgene in dividing 
germ-cells residing at basal compartment of tubules leading to its integration in native genome of mice. Such males generated 
transgenic progeny by natural mating. Several transgenic animals can be generated with minimum skill within short span of time 
by this easily adaptable novel technique.
Molecular Therapy — Methods & Clinical Development (2016) 3, 16076; doi:10.1038/mtm.2016.76; published online 7 December 2016
The first two authors contributed equally to this work.
1Embryo Biotechnology Laboratory, National Institute of Immunology, New Delhi, India; 2Department of Zoology, Dr. H. S. Gour University, Sagar, India; 3Current address: 
Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA; 4Current address: Department of Microbiology, University of Raiganj, West Bengal, 
India; 5National Institute of Animal Biotechnology, Hyderabad, Telangana, India. Correspondence: SS Majumdar (subeer@nii.ac.in)
Robust generation of transgenic mice by simple hypotonic 
solution mediated delivery of transgene in testicular germ cells
Abul Usmani1,2,3, Nirmalya Ganguli1, Subodh K Jain2, Nilanjana Ganguli1, Rajesh Kumar Sarkar1, Mayank Choubey1, Mansi Shukla1, 
Hironmoy Sarkar1,4 and Subeer S Majumdar1,5
ARTICle
2A shortcut method of transgenesis
A Usmani et al.
Molecular Therapy — Methods & Clinical Development (2016) 16076 Official journal of the American Society of Gene & Cell Therapy
like DNA in vivo without being killed and the sperm produced from 
transfected germ cells may carry desired DNA fragment (transgene) 
which can generate transgenic animal.
Motivated by the above hypothesis, and to circumvent the cave-
ats resident in previous procedures, here we report the develop-
ment of an easy and simple procedure for in vivo gene transfer in 
male germ cells of the testis for producing transgenic mice. Delivery 
of the transgene into germ cells was achieved by creating a hypo-
tonic environment surrounding spermatogonia upon testicular 
injection of linearized transgene suspended in the hypotonic solu-
tion of Tris-HCl.
Such a procedure enabling researcher’s to generate their own 
transgenic animals, instead of outsourcing, would drastically mini-
mize the time required for studies of functional genomics and facili-
tate research involving humanized transgenic models of diseases.
ReSUlTS
Transfection of nucleotides in testis by Tris-HCl solution
To test our hypothesis that hypotonicity generated through Tris-
HCl solution can help to transfect testicular germ cells in vivo, 
Tetramethylrhodamine (TRITC) labelled dUTP   molecules, which 
emits bright red fluorescence upon excitation with UV (RED-dUTP), 
was taken as reporter initially. RED-dUTP suspended in Tris-HCl solu-
tion was injected into testis of 30 ± 2 days old male mice. Earlier it was 
reported by us that testis of 30 ± 2 day old mice is suitable for testicular 
transgenesis.6 Initially the concentration of Tris-HCl was maintained 
at 20 mmol/l as reported earlier for treatment to germ cells in vitro.8 
No presence of RED-dUTP was observed in the tubules when isolated 
from testis. We investigated the possibilities of transfection with higher 
concentration of Tris-HCl (50, 100, and 150 mmol/l concentrations) 
with suspended RED-dUTP. We observed the presence of Red-dUTP 
fluorescence in seminiferous tubulues at 100 and 150 mmol/l concen-
tration, isolated from transfected testis (Supplementary Figure S1a).
Transgene transfection in testis by Tris-HCl solution
When it was found that Tris-HCl solution can deliver the nucleotides 
into the testis, linearized pCX-Egfp plasmid DNA, having enhanced 
green fluorescence protein (EGFP) reporter under ubiquitous pro-
moter, was taken for further validation. Variation in parameters were 
tried to achieve the best transfection in testis in vivo. Injection param-
eters such as amount of plasmid DNA (ranging from 10–30 µg/testis), 
volume of injection (ranging from 20–30 µl), number of injections per 
testis (1–4) and the concentration of Tris-HCl (ranging from 20–200 
mmol/l) were tested. Based on EGFP expression after 30 days of post-
transfection in testis, the best transfection in our case was observed 
with injection conditions of 150 mmol/l Tris-HCl, having 12.5 µg of 
plasmid DNA in a total volume of 25 µl, and two injection sites per tes-
tis of 30 ± 2 days old male FVB mice (Supplementary Figure S1b and 
Supplementary Table S1). In the cross-section of transfected testis, 
EGFP expression was observed. The EGFP expression was also found to 
be germ cells specific, confirmed by colocalization with VASA (Figure 
1a), a germ cell marker.10–12 In transfected tubules there are regions 
where transfected and nontransfected germ cells can be observed 
(Figure 1b). We observed no apparent adverse effect of Tris-HCl on 
transfected testicular tissue architecture (Supplementary Figure S1c).
Generation of transgenic mice mediated by Tris-HCl testis 
transfection
Based on our preliminary observations of Tris-HCl mediated trans-
fection of testicular germ cells, and stable expression of transgene 
even after 30 days of post-transfection, we expected that the sperm 
produce from the transfected germ cells should carry the transgene 
and could be used for generation of transgenic mice.
Implementing this new method we have generated trans-
genic mice using Bucsn2-IRES2-Egfp construct, which contain Egfp 
reporter gene under Buffalo Beta-casien (Bucsn2) promoter, which 
expresses specifically in mammary epithelial cells. The linearized 
construct of Bucsn2-IRES2-Egfp was suspended in 150 mmol/l Tris-
HCl and injected in both the testis of mice (G0 founder) at the age 
of 30 ± 2 days. G0 founders were cohabitated with wild type female 
mice 30 days post-transfection to obtain generation one (G1) prog-
eny. The presence of transgenic pups in G1 was detected by poly-
merase chain reaction (PCR) (Figure 2a). Transgenic female mice 
were housed until adulthood and put for mating to make them 
lactating. In such transgenic female mice, an intense endogenous 
EGFP fluorescence was seen in their mammary glands during 
period of lactation (Figure 2b), this observation was also confirmed 
by immunohistochemistry analysis (Figure 2c). The presence of 
EGFP was observed in the mammary tissue extract compared with 
wild type control, and no EGFP expression was found in other tissue 
types of the same transgenic female mice (Figure 2d). To evaluate 
whether the transgene in G1 can be carried forward to the next gen-
eration that is G2, transgene positive adult male and female mice 
from G1 were put for mating. PCR screening showed transgene 
positive G2 progeny indicating that the transgene was propagated 
to G2 (Figure 2a).
To further validate this newly developed method of transgenesis, 
we used two more constructs Amh-IRES2-Egfp and FetuinA-shRNA 
for generation of transgenic mice.
Amh-IRES2-Egfp construct carried Egfp under promoter of anti-
mullerian hormone (Amh) which is known to be expressed spe-
cifically in infant Sertoli cells. By PCR analysis transgene positive 
animals were detected in G1 (Figure 3a). Southern blot analysis 
was performed, using BamHI enzyme to digest the genomic DNA 
(gDNA) (Figure 3b), to determine transgene integration sites in the 
genome. It was found that in this transgenic mice line, there were 
mostly two types of integration of the delivered transgene in the 
genome. One is integration in tandem repeats which generated 
~5.3 kb band in southern blot and another is single copy integra-
tion for which a band at ~4 kb was observed in the same (Figure 3c). 
Immuno-histochemical analysis showed Sertoli cell specific expres-
sion of EGFP in the testis of 5 days old transgenic mice (Figure 3d) 
and there was an absence of EGFP expression in the other tissues 
of the same transgenic mice (Supplementary Figure S2a). As the 
Amh promoter is infant Sertoli cell specific, no EGFP expression was 
observed in testis at 42 days (postpubertal) of age (Supplementary 
Figure S2b). Western blot analysis with testicular extracts of 5 days 
old transgenic mice from G1 revealed presence of 28 KDa band cor-
responding to EGFP (Figure 3e).
In the construct FetuinA-shRNA, shRNA specific to the gene Ahsg 
(Alpha-2-HS-glycoprotein or Fetuin A) was cloned under ubiqui-
tous promoter U6. The transgenic progeny born in G1 from the G0 
founder transfected with this construct were screened by slot blot 
analysis (Figure 4a) but not with the usual PCR analysis, as in our 
case the PCR primer did not worked nicely on shRNA may be due to 
their stable hairpin loop structure. Quantitative real-time PCR analy-
sis of mRNA extracted from liver tissue revealed that expression lev-
els of Fetuin A mRNA was drastically reduced in transgenic mice as 
compared with that in wild type mice (Figure 4b). Von kossa staining 
of heart tissue from knockdown mice revealed increased calcifica-
tion of tissues, unlike wild type tissues (Figure 4c). We generated G2 
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of knock down animals by breeding two transgene positive animals 
from G1. Fetuin A expression was found to be reduced in liver of G2 
animals also, in comparison with wild type animals (Supplementary 
Figure S3).
There were 12 out of 17, 8 out of 25, and 16 out of 36 transgene 
positive animals as judged by genomic analysis of progeny born in 
G1 generation of Bucsn2-IRES2-Egfp, Amh-IRES2-Egfp, and FetuinA-
shRNA transgenic mice, respectively. Hence for this newly developed 
transgenesis technique, the overall efficiency to transmit a trans-
gene in the first generation was found to be 46% (Supplementary 
Table S2).
DISCUSSION
Development of a user-friendly method for rapidly generating 
transgenic mice without an extraordinary laboratory set up is a 
major unmet need of biomedical researchers. Rapidly generating 
outflow from modern DNA sequencing technologies has made this 
need more crucial. To this end, we have developed a technique for 
making mice which involves simple testicular injection of transgene 
suspended in hypotonic solution of 150 mmol/l Tris-HCl.
Hypotonic solution of 20 mmol/l Tris-HCl is usually used to dam-
age and remove the contaminating germ cells from cultures of 
primary Sertoli cells of testicular origin.8,13 A treatment with hypo-
tonic solution of 5–20 mmol/l Tris-HCl for 2.5 minutes results into 
hypotonic-swelling of germ cells.8 The higher concentration of 
Tris-HCl (30–80 mmol/l) was inefficient in harming the germ cells.8 
In another study with erythrocytes, hypotonic-swelling led to 
uptake of surrounding nucleosides, amino acids, and monosaccha-
rides via nonconventional Na+-independent pathway.9 This noncon-
ventional path way suggested to be nonspecific for uptake of mol-
ecules inside the cells.9 Here, in this study, we have exploited this 
cellular response toward hypotonocity and found that hypotonic 
solution containing Tris-HCl at a concentration of 150 mmol/l effec-
tively transfected DNA in testicular germ cells while they were being 
remained healthy. In the process of spermatogenesis, drastic divi-
sions of testicular germ cells occur with multiple mitotic divisions 
in the initial phases. In this dividing process genome of the germ 
cell goes through multiple synthesis phases leading to frequent 
unwinding of the DNA strands, making it vulnerable for integration 
and propagation of exogenous DNA fragments, if delivered in to the 
germ cells. Though there was a chance that other cell types of the 
testis might also respond to this induced hypotonicity and uptake 
the delivered transgene, we did not find the EGFP expression in to 
any other testicular cell type. The hypotonic effect of Tris-HCl does 
not harm the testis because it gets easily cleared along with the 
interstitial fluid which has a high turnover rate in the testis.14
To determine whether such transfection by hypotonic solution can 
lead to generation of transgenic animal, we have taken two tissue-
specific over expression constructs, namely Bucsn2-IRES2-Egfp and 
Amh-IRES2-Egfp, and a knock down construct, U6-shRNA against 
Fetuin A gene. We successfully generated transgenic progeny by this 
Figure 1  Transfection of transgene in the testis by hypotonic solution. (a) Enhanced green fluorescence protein (EGFP) expression in transfected testis 
transfected with pCX-Egfp suspended in 150 mmol/l Tris-HCl. i–v: Tissue Section of nontransfected testis. vi–x: Tissue section of transfected testis. EGFP 
expression was observed mostly in germ cells (yellow arrow head) of transfected testis. Lack of EGFP expression in nontransfected tubules and germ 
cells of treated testis (red arrow head). Note: Nonspecific signal (white head) in the interstitial space of the testis was observed in both treated and 
wildtype animal’s tissue section. Scale bar: 50 µm. (b) Seminiferous tubule showing EGFP in germ cells at higher magnification of the partial section of 
figure - a x. Scale bar: 50 µm. The thick white line is added for better differentiation of one tubuler region from another.
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new method from all the three constructs used in the study. In case 
of transgenic lactating females carrying Bucsn2-IRES2-Egfp transgene, 
very intense expression of EGFP was observed specifically in the mam-
mary glands. The transgene (Bucsn2-IRES2-Egfp) also propagated from 
generation one (G1) to generation two (G2), further confirming its 
stable integration in the genome. The results were found to be similar 
to our previous report where same construct was used to generate 
transgenic animals but by electroporation method.15 In Amh-lRES2-
Egfp transgenic line, Egfp gene was under regulation of murine Amh 
promoter. Amh is expressed at very high levels in immature Sertoli 
Figure 2 Generation of transgenic animal with Bucsn2-IRES2-Egfp construct. (a) Polymerase chain reaction (PCR) genotyping of the offspring from 
generation one (G1) and generation two (G2) to detect transgenic animal. In the G1 pups, except the TBa2, Tba7, TBc4-6 all are found to be PCR positive. 
Wt represents the genomic DNA (gDNA) from wild type animal as PCR negative control concludes that primer pair did not amplify the endogenous 
gene. +ve represents the plasmid construct DNA as a PCR positive control. (b) Mammary gland of lactating (day 7 of lactation) transgenic female mice 
(TBc 7) carrying Bucsn2-IRES2-Egfp transgene, as observed under stereozoom fluorescence microscope. Image (i) show the wild type mammary gland. 
Image (iii) show EGFP fluorescence in gland of transgenic mice. Image (ii) and (iv): corresponding phase contrast image of wild type and transgenic mice, 
respectively. (c) Immunohistochemistry to detect GFP expression in the mammary alveoli of female mice carrying Bucsn2-IRES2-Egfp transgene. GFP 
expression was observed in transgenic mice mammary gland (i) whereas there was no GFP expression in mammary gland of wild type mice (iii). Yellow 
arrow marks the presence of GFP expression in the milk space of transgenic mice mammary gland. Red arrow marks the absence of GFP expression 
in the milk space of wildtype mice mammary gland. Yellow line mark the boundary of mammary alveoli. Image ii and iv are the corresponding phase 
contrast image of transgenic (i) and wild type (iii). Scale bar 50 µm. (d) Expression of EGFP by western blot in protein from (i) mammary glands of three 
different transgenic females and two different wild type mice and (ii) various tissues (liver, spleen, brain, heart, mammary gland, and kidney) of lactating 
(day 7 of lactation) transgenic female mice (TBc 7) carrying Bucsn2-IRES2-Egfp transgene EGFP expression (~28 kDa) was observed in transgenic mice 
whereas there is no EGFP signal in wild type mice. EGFP expression (~28 kDa) was present only in mammary gland sample and not in other tissue type 
of the animal. β-actin was used as loading control. EGFP, enhanced green fluorescence protein.
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cells of the testis from 12.5 day postcoitum (dpc) in the mouse16 until 
the onset of testicular puberty17 (around 10 days of postnatal age). 
In transgenic mice carrying Amh-lRES2-Egfp, we could successfully 
detect the pattern of gene integrations in the genome by Southern 
blot analysis. Age specific expression of EGFP under control of Amh 
promoter in the Sertoli cells of 5 days old mice suggested successful 
Figure 3 Validation of Amh-IRES2-Egfp transgenic mice. (a) PCR genotyping of the offspring using genomic DNA (gDNA) obtained from G0 founder 
MG1 transfected with Amh-IRES2-Egfp. MG1 was mated with wild type female mice. MG denotes the G0 founder animal of Amh-IRES2-Egfp. MT 
denotes transgenic animal of Amh-IRES2-Egfp line. Wt denotes wild type mice. NT denotes no template. +ve denotes plasmid DNA. EGFP, enhanced 
green fluorescence protein; G1, Generation 1; MT, Pups from Amh-IRES2-Egfp Transgenic mice; PCR, polymerase chain reaction.(b) Position of BamH1 
restriction-enzyme and probe for southern blot on transgene construct. (c) Southern blot analysis of genomic DNA (gDNA) isolated from tail biopsy 
of Amh-IRES2-Egfp transgenic mice, showing integration of transgene in multiple sites. wt1 and wt2 denote gDNA isolated from two different wild 
type animals. MT21, MT22, MT23, and MT25 denotes gDNA isolated from different pups born from transgenic animals MG1, where 21, 22, and 25 were 
PCR positive and 23 was PCR negative pups. L denotes 1 kb DNA ladder (NEB, USA). The molecular weights of the bands mentioned in the ladder are 
in Kb. (d) EGFP expression in Sertoli cells of 5 days old Amh-IRES2-Egfp transgenic mice (i, ii) compared with the wild type control. Yellow arrow head 
shows the EGFP fluorescence in the Sertoli cells inside seminiferous tubules. White arrow marks the nonspecific staining in Leydig Cells. Scale bar: 10 
µm. (e) Detection of EGFP protein (~28 kDa band) by Western blot analysis from testis of 5 days old three transgenic mice compared with age matched 
wild-type mice testis. β-actin was used as loading control.
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expression of the integrated gene. This was further authenticated by 
Western blot analysis, which showed the presence EGFP in the tes-
ticular extracts from 5 days old transgenic mice but not in the extracts 
of testis from age matched wild type mice.
We have also evaluated the utility of this method in exerting RNA 
inhibition in vivo. Gene knockdown mice was generated using a 
construct carrying shRNA against mRNA of Fetuin A, a protein pre-
dominantly produced by the liver. Such mice displayed a significant 
(P < 0.05) decline in the levels of Fetuin A mRNA in the liver, suggest-
ing successful generation of knockdown mice by this procedure. 
Fetuin-A is a major inhibitor of calcification in soft tissues, especially 
that of heart, kidney, and lung. Deficiency of Fetuin-A is known to be 
associated with dystrophic calcification of these tissues.18 We found 
similar calcification in hepatic and cardiac tissue of our Fetuin-A 
knock-down mice generated by this procedure. This observation is 
in line with previous findings reported in Fetuin A knock-out mice 
generated using embryonic stem (ES) cells.18
The percentage of efficiency for getting a transgene positive ani-
mal was found to be about 46% by this method, which was higher 
than the conventional method of transgensis by pronuclear DNA 
injection method 10–20%,4,5 but lower than the earlier method 
which used gene electroporation in the testis.7 Although we found 
the overall transgenic efficiency for this method is 46% (positive 
animals from all constructs taken together), Bucsn2-IRES2-Egfp and 
Fetuin A-shRNA the efficiency (70%) was found to be higher (70%) 
and lower (32%), respectively than the average. This could be due 
to nature of constructs used for transfection which influenced 
their transfection efficiency into the testis. Considering the simplic-
ity of this hypotonic solution mediated transgenic method which 
requires no additional instruments and specific skills, we believe 
that this efficiency is quite sufficient to generate an adequate num-
ber of transgenic founder animals each of which can generate a line 
for any given biological study. Moreover, this innovative method 
can be extrapolated in large animal species like nonhuman pri-
mates and bovine where the generations of transgenic animal with 
the existing techniques are very cumbersome. We observed some 
variation in a number of positive pups generated with different con-
structs. There can be several factors which are responsible for these 
variations. The DNA constructs which are used in the development 
of this procedure are of different length. Although the length of the 
DNA does not affect the efficiency of integration,19 but it can affect 
transfection efficiency.20 So the variations in length of constructs 
might have resulted in variations in transfection of constructs in 
the germ cells, which might have resulted in the variation seen in 
the number of transgenic pups obtained with different constructs. 
Another reason for various numbers of positive offspring could be 
the type and number of restriction enzymes used for linearizing the 
construct before transfection. It was previously reported that the 
end sequences of linearized DNA can lead to variation in integra-
tion frequency.20
In conclusion, we have developed a novel and simple method for 
making transgenic mice avoiding any harsh treatment to animals. 
Figure 4 Evaluation of Fetuin A knockdown in mice. (a) Slot blot analysis of the progeny from generation one (G1) obtained from the G0 founder males 
transfected with Fetuin A-shRNA; 1FT, 2FT, and 3FT are three different G0 founder males. FT denotes Fetuin- A shRNA expressing transgenic mice. Wt 
denotes wild type mice. (b) Relative fold changes in Fetuin A mRNA expression of transgenic animals relative to wild type animals. wt, wild type mice, 
FT10–F15 represents five different transgenic animals. Each bar generated from n = 3 qRTPCR of same sample, represented as mean ± SEM. ***P < 0.001. 
(c) Von kossa staining in Fetuin A knockdown mice for detection of increased calcium deposition in heart (black spots). (i) Wild type, (ii) Transgenic, and 
(iii) Enlarged view of Transgenic Heart. SEM, standard error of the mean; qRTPCR, quantitative real time polymerase chain reaction.
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This procedure is fast and can be easily adapted by researchers since 
it does not require any dedicated laboratory, equipment or special-
ized expertise to handle embryos. Moreover, it does not involve sacri-
fice of any animal or use of electric pulses for testicular gene transfer 
making this technique ethically more acceptable. This easy procedure 
of in-vivo transgenesis by simple injection of a suspension of DNA in 
the testis provides a remarkable scope to biomedical researchers for 
generating their own transgenic animal models thereby potentially 
adding pace to the field of functional genomics.
MATeRIAlS AND MeTHODS
Animals
FVB/NJ strain of mice was used for this study. The mice were housed in a 
climate controlled environment under standard light (14-hour light, 10-hour 
dark cycle), temperature (23 ± 1°C), and humidity (50 ± 5%). Animals were 
used as per the National Guidelines provided by the Committee for the 
Purpose of Control and Supervision of the Experiments on Animals (CPCSEA), 
Government of India. Protocols for the experiments were approved by 
the Institutional Animal Ethics Committee (IAEC), National Institute of 
Immunology, New Delhi.
Plasmids
pCX-Egfp plasmid was a kind gift from Y. Junming (University of Tennesse, 
Memphis, USA), it contains chicken beta actin promoter along with cyto-
megalovirus transcription enhancer element (CX) and an egfp gene.The 
plasmid was digested with Sal I restriction enzyme to obtain a single frag-
ment of 5.5 kb which was used for the testicular injection during standard-
ization of the procedure (Supplementary Figure S4a).
Amh-IRES2-Egfp For this construct, 632 bp upstream region of the Amh 
gene spanning from −1 bp to −632 bp from transcription start site of 
mouse Amh gene was PCR amplified (GenBank accession no. KJ026118.1) 
from mouse genome and cloned in pIRES2-Egfp vector to generate Amh-
IRES2-Egfp construct. Amh-IRES2-Egfp plasmid DNA was digested with AseI 
and NheI restriction enzymes, the fragment of interest (5.3 kb) had Amh 
promoter at 5′ end and egfp gene toward the 3′ end (Supplementary 
Figure S4b).
Bucsn2-IRES2-Egfp. This construct expresses egfp gene under Buffalo beta 
casein promoter (GenBank accession no. KF612339.1).15 Bucsn2-IRES2-Egfp 
plasmid DNA was digested with PstI and SfoI restriction enzymes. The frag-
ment of interest (~6.8 kb) had Bucsn2 promoter at 5′ end and egfp gene 
toward the 3′ end (Supplementary Figure S4c).
Fetuin A-shRNA construct. Fetuin A-shRNA bacterial clones targeting mouse 
Fetuin A gene were procured from Sigma-Aldrich,  St. Louis, Missouri, USA. 
The shRNA sequence was cloned in pLKO.1-puro vector21 between U6 pro-
moter (RNA polymerase III promoter) and central polypurine tract (cPPT). 
Fetuin-AshRNA plasmid DNA was linearized with NcoI restriction enzyme to 
obtain 7.1 kb fragment, which was used to make transgenic mice (Supple-
mentary Figure S4d).
Preparation of plasmid DNA
Plasmid DNA was isolated from overnight grown culture of E. coli (dh5α) 
using plasmid DNA isolation kit (Advanced Micro Devices, India) and 
assessed for quality and quantity of DNA was assessed spectrophoto-
metrically. Samples were checked on 1% agarose gel to check for integ-
rity. Plasmid DNA was digested by appropriate restriction enzymes to take 
out the functional cassette and was purified by gel extraction kit (Qiagen). 
Purified DNA was also assessed spectrophotometrically and on agarose gel, 
before injection in to testis.
Labeled nucleoside RED-dUTP transfection in to testis
Seminiferous tubules of the 30 days old FVB mice testis were injected 
with Tetramethylrhodamine (TRITC) fluorophore labelled dUTP nucleotide 
(Abbott Molecular, IL), suspended in different concentration of Tris-HCl 
hypotonic solution (50, 100, and 150 mmol/l) of pH 7.0. After 2 hours, tes-
tis were dissected out and teased to expose the tubules out of the tunica 
albuginea. Tubules were washed thrice with phosphate buffered saline (PBS) 
and observed under ultraviolet for the presence of fluorescence inside the 
seminiferous tubules.
Hypotonic solution mediated in vivo gene transfer in testicular 
germ cells
Male mice (30 ± 2 days postbirth) were anesthetized using intraperitonial 
injection (~120 µl) of a mixture of ketamine (45 mg/kg) and xylazine (8 mg/
kg). Hairs from the scrotal area were trimmed, followed by disinfection with 
Betadiene. The area was rinsed after 2 minutes with 70% alcohol, leaving the 
area clean and moist. Gently testis was pushed down from abdominal cavity 
with the help of thumb and index finger. Plasmid DNA suspended in Tris-HCl 
solution (concentrations ranging from 20 mmol/l to 200 mmol/l during stan-
dardization) of pH 7.0, along with 0.04% Trypan blue and was injected slowly 
in to the descended testis using 26 gauge 10 µl volume Hamilton syringe 
(701N; Hamilton Bonaduz AG, Switzerland). For standardization, a range of 
20–30 µl of hypotonic solution containing various concentration of linear-
ized plasmid DNA (0.5–1.5 µg/µl) was delivered into single testis. Variation 
in the concentration of Tris-HCl solution, concentration of plasmid DNA and 
number of injection sites (1–4) were done at the time of standardization of 
this technique (Supplementary Figure S5).
Generation and screening of transgenic lines
Two constructs for overexpression and one construct for down regulation by 
shRNA were used for development and validation of this new procedure. The 
injected mice (G0 founders) were put for natural mating with wild type adult 
females after 30–35 days postinjection (mice age 60–65 days) and gDNA of 
progeny were analyzed for the presence of transgene. For this purpose, tail 
biopsies were obtained at 21 days of age and gDNA of mice was extracted 
from respective tissue. Presence of transgene in the gDNA was determined 
by PCR using transgene-specific primers (Supplementary Table S3). PCR was 
performed using the standard protocol. The PCR products were analyzed by 
TAE agarose gel electrophoresis. To rule out the possibility of false positives 
in the PCR, negative controls such as a reaction with the gDNA of the wild-
type (FVB) mice, were performed. For positive control, a reaction was per-
formed using 20 ng of pBucsn2–IRES2–Egfp plasmid DNA.
The gDNA of pups was also analyzed for gene integration by Slot blot 
analysis for transgene constructs bearing shRNA. In brief, probe identi-
fying the transgene fragment was generated by αP32dCTP using High 
Prime DNA labeling kit (Roche Diagnostic GmbH, Mannheim, Germany). 
Denatured gDNA (1 µg) was blotted on Hybond N+ (Amersham Pharmacia 
Biotech, England) membrane with slot blot apparatus (Cleaver Scientific, 
Warwickshire, UK) under vacuum. The membranes were prehybridized for 
4 hours, followed by hybridization with respective transgene specific probes 
for 10–12 hours. The hybridized blot was exposed to Kodak BioMax MR Film 
(Kodak, Rochestar, New York) for detection of signals by autoradiography.
Southern blot analysis
Southern blot analysis was performed following standard procedure.22 
About 10 µg of gDNA obtained from transgenic progeny of G1 generation 
was digested with BamHI restriction endonuclease enzyme. The enzyme has 
one digestion site in the transgene (~5.3 kb) that generates two fragments 
(~1.3 and 4 kb). The southern blot probe was generated on the longer frag-
ment (4 kb). Therefore in the southern blot in a transgenic sample the molec-
ular weight of positive band will be ~4 kb or higher. Digested product was 
resolved on 1% agarose gel, and transferred to Hybond N+ (GE Healthcare, 
England). An Egfp probe fragment of ~600 bp was labeled with αP32dCTP 
using High Prime DNA labeling kit (Roche Diagnostic GmbH) and was used 
to detect the transgene integrations. The membrane was hybridized for 
20 hours and was exposed to Kodak BioMax MS film (Kodak, Rochestar) for 
detection of signals by autoradiography.
Observation of in vivo EGFP expression in breast glands
EGFP expression was observed in the breast gland of lactating female as 
described by us previously.15
Histology and immunohistochemistry
For histology, tissues were dissected, fixed in formalin and processed for 
paraffin embedding. Sections were stained by hematoxylin and eosin or 
with Vonkossa stain. We determined the expression of EGFP in the seminif-
erous tubule of pCX-Egfp and Amh-IRES2-Egfp transgenic mice by immuno-
histochemistry. Testis sections of 5 µm were subjected to immunostaining 
with mouse anti-EGFP (Clontech, Mountain View, CA) as primary antibody 
at a dilution of 1:200 and then antimouse IgG tagged to Alexafluor 488 
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(Molecular probes, Eugene, OR) was used at a dilution of 1:250, as secondary 
antibody. The fluorescence was detected by Nikon Eclipse Ti inverted fluo-
rescence microscope (Nikon, Chiyoda-ku,Tokyo, Japan). The images were 
captured using Nikon-digital sight DS-Ri1 camera.
Western blot analysis
Tissue lysates from testis of Amh-IRES2-Egfp transgenic mice; mammary 
gland, liver, spleen, brain, heart, and kidney of Bucsn2-IRES2-Egfp transgenic 
mice were used to determine presence of EGFP. About 30 μg of protein sam-
ple was resolved on 12% sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to Polyvinylidene difluoride (PVDF) 
membranes (MDI, India). The membranes were first incubated with primary 
antibody (mouse anti-EGFP) at 1:1,000 dilutions followed by antimouse sec-
ondary antibody conjugated with horseradish peroxidase at 1:5,000 dilu-
tions. The protein bands were detected using enhanced chemiluminescence 
method (ECL, Amersham Biosciences, UK).
RNA isolation and real-time PCR
RNA was isolated from liver tissue of Fetuin-A knockdown transgenic mice and 
wild type mice using TRIzol (Sigma Chemical). Real time PCR was performed 
using primer specific for Fetuin-A gene (5′TCACAGATCCAGCCAAATGC3′ as 
forward primer and 5′GGAATAACTTGCAGGCCACT3′ as reverse Primer). 
RNA (1 µg) was treated with DNase I (1 unit; Fermentas, Pittsburgh, PA) for 
30 minutes at 37°C. Reaction was terminated by adding 1 µl of 25 mmol/l 
ethylenediaminetetraacetate (EDTA) and incubating at 65°C for 10 minutes. 
DNaseI treated RNA was reverse transcribed using Reverse Transcription 
System (Eurogentec, Seraing, Belgium) with MuMLV reverse transcrip-
tase enzyme and oligo-dT (15mer) for the single-strand cDNA synthesis. 
Real time PCR amplifications were performed in the Realplex (Eppendorf, 
Hamburg, Germany) in a total volume of 10 µl, which included 1 µl of 
cDNA, 5 µl of Power SYBR Green Master Mix (Applied Biosystems, CA) and 
0.5 µl of each primer. Expression of glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) (using 5′AGAACATCATCCCTGCATCC 3′ as forward primer 
and 5′CACATTGGGGGTAGGAACAC3′ as reverse Primer) was analyzed for 
use as an endogenous housekeeping gene control. Relative fold change of 
Fetuin-A mRNA in transgenic animal with respect to wild type mice was cal-
culated by 2ΔΔct method.23
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